We are live on ! Find out more
CIC

Cornercap Investment Counsel Portfolio holdings

AUM $203M
1-Year Est. Return 17.67%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+17.67%
3 Year Est. Return
+55.44%
5 Year Est. Return
+79.88%
10 Year Est. Return
+193.02%
AUM
$649M
AUM Growth
+$38.4M
Cap. Flow
+$1.52M
Cap. Flow %
0.23%
Top 10 Hldgs %
8.38%
Holding
684
New
103
Increased
174
Reduced
151
Closed
77

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$2.43M
2
LMT icon
Lockheed Martin
LMT
+$2.07M
3
WFC icon
Wells Fargo
WFC
+$2.06M
4
SPGI icon
S&P Global
SPGI
+$2.04M
5
TFC icon
Truist Financial
TFC
+$1.8M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$2.6M
2
PH icon
Parker-Hannifin
PH
+$2.49M
3
AVGO icon
Broadcom
AVGO
+$2.4M
4
AXP icon
American Express
AXP
+$2.36M
5
CB icon
Chubb
CB
+$2.07M

Sector Composition

Rank Sector Weight
1 Financials 18.76%
2 Technology 17.7%
3 Healthcare 14.05%
4 Industrials 12.92%
5 Consumer Discretionary 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VERV
576
DELISTED
Verve Therapeutics
VERV
$175K 0.03%
+13,178
New +$175K
FHTX icon
577
Foghorn Therapeutics
FHTX
$371M
$173K 0.03%
25,819
– –
FHN icon
578
First Horizon
FHN
$12B
$164K 0.03%
10,662
– –
EDIT icon
579
Editas Medicine
EDIT
$432M
$150K 0.02%
20,160
+146
+0.7% +$1.21K
ALEC icon
580
Alector
ALEC
$189M
$148K 0.02%
24,532
– –
VNDA icon
581
Vanda Pharmaceuticals
VNDA
$304M
$135K 0.02%
32,895
– –
ERAS icon
582
Erasca
ERAS
$6.29B
$120K 0.02%
58,045
– –
ALXO icon
583
ALX Oncology
ALXO
$285M
$116K 0.02%
+10,440
New +$147K
CUE icon
584
Cue Biopharma
CUE
$110M
$109K 0.02%
1,930
– –
ACET icon
585
Adicet Bio
ACET
$75.9M
$89.8K 0.01%
2,388
– –
BTE icon
586
Baytex Energy
BTE
$3.06B
$70K 0.01%
19,277
-5,610
-23% -$18.2K
KRON
587
DELISTED
Kronos Bio
KRON
$53.8K 0.01%
41,351
– –
IMA
588
ImageneBio Inc
IMA
$64.9M
$51.3K 0.01%
3,013
– –
ADNT icon
589
Adient
ADNT
$1.44B
– –
-25,547
Closed -$929K
AEE icon
590
Ameren
AEE
$29.6B
– –
-3,220
Closed -$233K
AHRT
591
AH Realty Trust
AHRT
$503M
– –
-65,064
Closed -$805K
AMLX icon
592
Amylyx Pharmaceuticals
AMLX
$2.53B
– –
-44,487
Closed -$655K
GOLD
593
Gold.com Inc
GOLD
$1.26B
– –
-13,131
Closed -$397K
ARVN icon
594
Arvinas
ARVN
$588M
– –
-6,727
Closed -$277K
AVNW icon
595
Aviat Networks
AVNW
$270M
– –
-16,447
Closed -$537K
AXP icon
596
American Express
AXP
$229B
– –
-12,621
Closed -$2.36M
BCBP icon
597
BCB Bancorp
BCBP
$155M
– –
-34,101
Closed -$438K
BDC icon
598
Belden
BDC
$5.28B
– –
-6,457
Closed -$499K
BOOM icon
599
DMC Global
BOOM
$153M
– –
-28,678
Closed -$540K
CCCC icon
600
C4 Therapeutics
CCCC
$400M
– –
-46,286
Closed -$262K
22 23
24
25 26

Similar funds

NWM
NRI Wealth Management Santa Clara, California $196M AUM 32.41% 1-Year Est. Return
EECFX
EnCap Energy Capital Fund X Houston, Texas $216M AUM 11.92% 1-Year Est. Return
PSB
Passumpsic Savings Bank St. Johnsbury, Vermont $183M AUM
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
NMG
New Millennium Group Sandy, Utah $231M AUM 33.06% 1-Year Est. Return
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
BC
Bowman & Company Oshkosh, Wisconsin $237M AUM 16.16% 1-Year Est. Return
EFA
Edge Financial Advisors Wheaton, Illinois $238M AUM 17.31% 1-Year Est. Return

Cornercap Investment Counsel's Q1 2024 Portfolio in Review

As of Q1 2024, Cornercap Investment Counsel held 684 positions worth $649M, up 6.3% from $611M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

Cornercap Investment Counsel's Q1 2024 filing shows 103 new, 174 increased, 151 reduced and 77 closed positions. Its largest new stake was Lockheed Martin: 4,734 shares worth $2.15M. The largest sale was CVS Health, an estimated $2.6M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

  • Cornercap Investment Counsel's largest Q1 2024 buy was Lockheed Martin: 4,734 shares worth $2.15M.
  • Cornercap Investment Counsel added most to Applied Materials in Q1 2024, an estimated $2.43M increase.
  • Cornercap Investment Counsel's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.4M.
  • Cornercap Investment Counsel fully exited CVS Health in Q1 2024, selling an estimated $2.6M.
  • Cornercap Investment Counsel's ten largest holdings make up 8.4% of its $649M portfolio in Q1 2024.
  • Cornercap Investment Counsel opened 103 new positions and closed 77 in Q1 2024.
  • Cornercap Investment Counsel's portfolio value rose 6.3% quarter-over-quarter to $649M.

Based on Cornercap Investment Counsel's 13F filing for Q1 2024, filed 10 May 2024.